{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:39:46Z","timestamp":1791488386079,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fragile X mental retardation protein (FMRP) binds to and regulates the translation of amyloid-\u03b2 protein precursor (<jats:italic>App<\/jats:italic>) mRNA, but the detailed mechanism remains to be determined. Differential methylation of <jats:italic>App<\/jats:italic> mRNA could underlie FMRP binding, message localization and translation efficiency. We sought to determine the role of FMRP and N<jats:sup>6<\/jats:sup>-methyladeonsine (m<jats:sup>6<\/jats:sup>A) on nuclear export of <jats:italic>App<\/jats:italic> mRNA. We utilized the m<jats:sup>6<\/jats:sup>A dataset by Hsu and colleagues to identify m<jats:sup>6<\/jats:sup>A sites in <jats:italic>App<\/jats:italic> mRNA and to determine if the abundance of message in the cytoplasm relative to the nucleus is altered in <jats:italic>Fmr1<\/jats:italic> knockout mouse brain cortex. Given that processing of APP to A\u03b2 and soluble APP alpha (sAPP\u03b1) contributes to disease phenotypes, we also investigated whether <jats:italic>Fmr1<\/jats:italic><jats:sup><jats:italic>KO<\/jats:italic><\/jats:sup> associates with nuclear export of the mRNAs for APP protein processing enzymes, including \u03b2-site amyloid cleaving enzyme (Bace1), A disintegrin and metalloproteinases (Adams), and presenilins (Psen). <jats:italic>Fmr1<\/jats:italic><jats:sup>KO<\/jats:sup> did not alter the nuclear\/cytoplasmic abundance of <jats:italic>App<\/jats:italic> mRNA. Of 36 validated FMRP targets, 35 messages contained m<jats:sup>6<\/jats:sup>A peaks but only <jats:italic>Agap2<\/jats:italic> mRNA was selectively enriched in <jats:italic>Fmr1<\/jats:italic><jats:sup><jats:italic>KO<\/jats:italic><\/jats:sup> nucleus. The abundance of the APP processing enzymes <jats:italic>Adam9<\/jats:italic> and <jats:italic>Psen1<\/jats:italic> mRNA, which code for a minor alpha-secretase and gamma-secretase, respectively, were selectively enriched in wild type cytoplasm.<\/jats:p>","DOI":"10.1038\/s41598-020-66394-y","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T10:40:20Z","timestamp":1593600020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["FMRP Regulates the Nuclear Export of Adam9 and Psen1 mRNAs: Secondary Analysis of an N6-Methyladenosine Dataset"],"prefix":"10.1038","volume":"10","author":[{"given":"Cara J.","family":"Westmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid S.","family":"Alisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah K.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debomoy K.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"66394_CR1","unstructured":"Hagerman, R. J. & Hagerman, P. J. In Physical and behavioral phenotype (eds. Hagerman, R. J. & Cronister, A.) pp.3-109 (John Hopkins University Press, Baltimore, 2002)."},{"key":"66394_CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nrn1667","volume":"6","author":"C Bagni","year":"2005","unstructured":"Bagni, C. & Greenough, W. T. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat. Rev. Neurosci. 6, 376\u2013387 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"66394_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/hmg\/10.4.329","volume":"10","author":"B Laggerbauer","year":"2001","unstructured":"Laggerbauer, B., Ostareck, D., Keidel, E. M., Ostareck-Lederer, A. & Fischer, U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10, 329\u2013338 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"66394_CR4","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/nar\/29.11.2276","volume":"29","author":"Z Li","year":"2001","unstructured":"Li, Z. et al. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29, 2276\u20132283 (2001).","journal-title":"Nucleic Acids Res."},{"key":"66394_CR5","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1093\/hmg\/11.24.3007","volume":"11","author":"R Mazroui","year":"2002","unstructured":"Mazroui, R. et al. Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression. Hum. Mol. Genet. 11, 3007\u20133017 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"66394_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(01)00568-2","volume":"107","author":"V Brown","year":"2001","unstructured":"Brown, V. et al. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477\u2013487 (2001).","journal-title":"Cell"},{"key":"66394_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(01)00566-9","volume":"107","author":"JC Darnell","year":"2001","unstructured":"Darnell, J. C. et al. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell 107, 489\u2013499 (2001).","journal-title":"Cell"},{"key":"66394_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0896-6273(03)00034-5","volume":"37","author":"KY Miyashiro","year":"2003","unstructured":"Miyashiro, K. Y. et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37, 417\u2013431 (2003).","journal-title":"Neuron"},{"key":"66394_CR9","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s11064-013-1229-3","volume":"39","author":"F Sethna","year":"2014","unstructured":"Sethna, F., Moon, C. & Wang, H. From FMRP function to potential therapies for fragile X syndrome. Neurochem. Res. 39, 1016\u20131031 (2014).","journal-title":"Neurochem. Res."},{"key":"66394_CR10","first-page":"23","volume":"78","author":"The Dutch-Belgian Fragile X Consortium","year":"1994","unstructured":"The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78, 23\u201333 (1994).","journal-title":"Cell"},{"key":"66394_CR11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"JC Darnell","year":"2011","unstructured":"Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247\u2013261 (2011).","journal-title":"Cell"},{"key":"66394_CR12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.celrep.2019.06.072","volume":"28","author":"BM Edens","year":"2019","unstructured":"Edens, B. M. et al. FMRP Modulates Neural Differentiation through m(6)A-Dependent mRNA Nuclear Export. Cell. Rep. 28, 845\u2013854.e5 (2019).","journal-title":"Cell. Rep."},{"key":"66394_CR13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue, Y., Liu, J. & He, C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 29, 1343\u20131355 (2015).","journal-title":"Genes Dev."},{"key":"66394_CR14","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/1873-3468.13107","volume":"592","author":"P Knuckles","year":"2018","unstructured":"Knuckles, P. & Buhler, M. Adenosine methylation as a molecular imprint defining the fate of RNA. FEBS Lett. 592, 2845\u20132859 (2018).","journal-title":"FEBS Lett."},{"key":"66394_CR15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fgene.2018.00510","volume":"9","author":"N Neriec","year":"2018","unstructured":"Neriec, N. & Percipalle, P. Sorting mRNA Molecules for Cytoplasmic Transport and Localization. Front. Genet. 9, 510 (2018).","journal-title":"Front. Genet."},{"key":"66394_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jnc.14481","volume":"147","author":"J Widagdo","year":"2018","unstructured":"Widagdo, J. & Anggono, V. The m6A-epitranscriptomic signature in neurobiology: from neurodevelopment to brain plasticity. J. Neurochem. 147, 137\u2013152 (2018).","journal-title":"J. Neurochem."},{"key":"66394_CR17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.celrep.2018.07.013","volume":"24","author":"T Suganuma","year":"2018","unstructured":"Suganuma, T. et al. MPTAC Determines APP fragmentation via sensing sulfur amino acid catabolism. Cell. Rep. 24, 1585\u20131596 (2018).","journal-title":"Cell. Rep."},{"key":"66394_CR18","doi-asserted-by":"crossref","first-page":"19889","DOI":"10.1074\/jbc.AC119.010078","volume":"294","author":"PJ Hsu","year":"2019","unstructured":"Hsu, P. J. et al. The RNA-binding protein FMRP facilitates the nuclear export of N\n6-methyladenosine-containing mRNAs. J. Bio. Chem. 294, 19889\u201319895 (2019).","journal-title":"J. Bio. Chem."},{"key":"66394_CR19","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pbio.0050052","volume":"5","author":"CJ Westmark","year":"2007","unstructured":"Westmark, C. J. & Malter, J. S. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 5, e52 (2007).","journal-title":"PLoS Biol."},{"key":"66394_CR20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nsmb.1815","volume":"17","author":"EK Lee","year":"2010","unstructured":"Lee, E. K. et al. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat. Struct. Mol. Biol. 17, 732\u2013739 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66394_CR21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/08830738060210062201","volume":"21","author":"DK Sokol","year":"2006","unstructured":"Sokol, D. K. et al. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J. Child Neurol. 21, 444\u2013449 (2006).","journal-title":"J. Child Neurol."},{"key":"66394_CR22","first-page":"338","volume":"1","author":"AR Bailey","year":"2008","unstructured":"Bailey, A. R. et al. Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int. J. Clin. Exp. Med. 1, 338\u2013344 (2008).","journal-title":"J. Clin. Exp. Med."},{"key":"66394_CR23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/mp.2016.134","volume":"21","author":"CJ Westmark","year":"2016","unstructured":"Westmark, C. J., Sokol, D. K., Maloney, B. & Lahiri, D. K. Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism. Mol. Psychiatry 21, 1333\u20131341 (2016).","journal-title":"Mol. Psychiatry"},{"key":"66394_CR24","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1007\/s12035-018-1344-x","volume":"56","author":"CJ Westmark","year":"2019","unstructured":"Westmark, C. J. Fragile X and APP: a Decade in Review, a Vision for the Future. Mol. Neurobiol. 56, 3904\u20133921 (2019).","journal-title":"Mol. Neurobiol."},{"key":"66394_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","volume":"15","author":"Y Fu","year":"2014","unstructured":"Fu, Y., Dominissini, D., Rechavi, G. & He, C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat. Rev. Genet. 15, 293\u2013306 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"66394_CR26","doi-asserted-by":"publisher","unstructured":"Chang, M. et al. Region-specific RNA m(6)A methylation represents a new layer of control in the gene regulatory network in the mouse brain. Open Biol. 7, https:\/\/doi.org\/10.1098\/rsob.170166 (2017).","DOI":"10.1098\/rsob.170166"},{"key":"66394_CR27","first-page":"3936","volume":"27","author":"F Zhang","year":"2018","unstructured":"Zhang, F. et al. Fragile X mental retardation protein modulates the stability of its m6A-marked messenger RNA targets. Hum. Mol. Genet. 27, 3936\u20133950 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"66394_CR28","doi-asserted-by":"crossref","first-page":"17249","DOI":"10.1021\/jacs.7b09213","volume":"139","author":"AE Arguello","year":"2017","unstructured":"Arguello, A. E., DeLiberto, A. N. & Kleiner, R. E. RNA Chemical Proteomics Reveals the N(6)-Methyladenosine (m(6)A)-Regulated Protein-RNA Interactome. J. Am. Chem. Soc. 139, 17249\u201317252 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"66394_CR29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nsmb.3462","volume":"24","author":"RR Edupuganti","year":"2017","unstructured":"Edupuganti, R. R. et al. N(6)-methyladenosine (m(6)A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24, 870\u2013878 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66394_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0169-328X(94)90125-2","volume":"24","author":"S Ledoux","year":"1994","unstructured":"Ledoux, S., Nalbantoglu, J. & Cashman, N. R. Amyloid precursor protein gene expression in neural cell lines: influence of DNA cytosine methylation. Brain Res. Mol. Brain Res. 24, 140\u2013144 (1994).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"66394_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2005.10.006","volume":"1067","author":"ST Mani","year":"2006","unstructured":"Mani, S. T. & Thakur, M. K. In the cerebral cortex of female and male mice, amyloid precursor protein (APP) promoter methylation is higher in females and differentially regulated by sex steroids. Brain Res. 1067, 43\u201347 (2006).","journal-title":"Brain Res."},{"key":"66394_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12264-016-0052-7","volume":"32","author":"Y Hou","year":"2016","unstructured":"Hou, Y. et al. Expression Profiles of SIRT1 and APP Genes in Human Neuroblastoma SK-N-SH Cells Treated with Two Epigenetic Agents. Neurosci. Bull. 32, 455\u2013462 (2016).","journal-title":"Neurosci. Bull."},{"key":"66394_CR33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/15257770.2015.1071844","volume":"34","author":"KV Nguyen","year":"2015","unstructured":"Nguyen, K. V. Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome. Nucleosides Nucleotides Nucleic Acids 34, 674\u2013690 (2015).","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"66394_CR34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.arr.2012.03.005","volume":"11","author":"CJ Westmark","year":"2012","unstructured":"Westmark, C. J. & Malter, J. S. The regulation of AbetaPP expression by RNA-binding proteins. Ageing Res. Rev. 11, 450\u2013459 (2012).","journal-title":"Ageing Res. Rev."},{"key":"66394_CR35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","volume":"163","author":"KD Meyer","year":"2015","unstructured":"Meyer, K. D. et al. 5\u2019 UTR m(6)A Promotes Cap-Independent Translation. Cell 163, 999\u20131010 (2015).","journal-title":"Cell"},{"key":"66394_CR36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","volume":"24","author":"JM Long","year":"2019","unstructured":"Long, J. M., Maloney, B., Rogers, J. T. & Lahiri, D. K. Novel upregulation of amyloid-beta precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5\u2019-untranslated region: Implications in Alzheimer\u2019s disease. Mol. Psychiatry 24, 345\u2013363 (2019).","journal-title":"Mol. Psychiatry"},{"key":"66394_CR37","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","volume":"492","author":"M Ascano Jr","year":"2012","unstructured":"Ascano, M. Jr et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature 492, 382\u2013386 (2012).","journal-title":"Nature"},{"key":"66394_CR38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma, A. et al. Dysregulation of mTOR signaling in fragile X syndrome. J. Neurosci. 30, 694\u2013702 (2010).","journal-title":"J. Neurosci."},{"key":"66394_CR39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.celrep.2015.03.060","volume":"11","author":"C Gross","year":"2015","unstructured":"Gross, C. et al. Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome. Cell. Rep. 11, 727\u2013736 (2015).","journal-title":"Cell. Rep."},{"key":"66394_CR40","doi-asserted-by":"crossref","first-page":"e919311","DOI":"10.12659\/MSM.919311","volume":"26","author":"X Quan","year":"2020","unstructured":"Quan, X. et al. Related Network and Differential Expression Analyses Identify Nuclear Genes and Pathways in the Hippocampus of Alzheimer Disease. Med. Sci. Monit. 26, e919311 (2020).","journal-title":"Med. Sci. Monit."},{"key":"66394_CR41","doi-asserted-by":"crossref","first-page":"134403","DOI":"10.1016\/j.neulet.2019.134403","volume":"711","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Wang, M., Marcora, E. M., Zhang, B. & Goate, A. M. Promoter DNA hypermethylation - Implications for Alzheimer\u2019s disease. Neurosci. Lett. 711, 134403 (2019).","journal-title":"Neurosci. Lett."},{"key":"66394_CR42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuron.2015.06.032","volume":"87","author":"E Pasciuto","year":"2015","unstructured":"Pasciuto, E. et al. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome. Neuron 87, 382\u2013398 (2015).","journal-title":"Neuron"},{"key":"66394_CR43","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/emboj.2010.167","volume":"29","author":"PH Kuhn","year":"2010","unstructured":"Kuhn, P. H. et al. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020\u20133032 (2010).","journal-title":"EMBO J."},{"key":"66394_CR44","doi-asserted-by":"crossref","first-page":"40443","DOI":"10.1074\/jbc.M111.280495","volume":"286","author":"ML Moss","year":"2011","unstructured":"Moss, M. L. et al. ADAM9 inhibition increases membrane activity of ADAM10 and controls alpha-secretase processing of amyloid precursor protein. J. Biol. Chem. 286, 40443\u201340451 (2011).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66394-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66394-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:09:47Z","timestamp":1670332187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66394-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66394"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66394-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.K.L. is a member of the advisory boards for Entia Biosciences and Provaidya LLC. He also has stock options from QR Pharma for patents or patents pending on AIT-082, Memantine, Acamprosate, and GILZ analogues. All have no direct influence on the research presented here. There are no competing interests for the other authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10781"}}